Particle.news

Centene Returns to Profit and Raises 2026 Forecast

Centene said narrower medical costs from improved Marketplace pricing, higher risk‑adjustment receipts and cost cuts prompted the guidance boost while a steep drop in Marketplace membership leaves the recovery uncertain.

Overview

  • Centene reported a second-quarter net income of $1.09 billion and an adjusted EPS of $2.51, beating analysts’ expectations.
  • The company said its health benefits ratio fell to 89.6% from 93% a year earlier, a change it credited to better pricing on Marketplace plans, higher risk‑adjustment payments that compensate for sicker enrollees, and targeted cost controls.
  • Total membership declined to about 25.9 million from more than 28 million year‑over‑year, with Marketplace enrollment falling sharply to 3.5 million from 5.8 million, reducing the pool of premium revenue.
  • Management raised full‑year revenue guidance to $193.5 billion–$197.5 billion and lifted 2026 adjusted profit guidance to above $4.80 per share, a move that pushed the stock modestly higher in premarket trading.
  • Analysts said the key test is whether Centene can sustain margin improvement into 2027 given enrollment shifts and policy-driven affordability pressures that could reverse recent gains.